On the Agewyz podcast, Shannon Brownlee and Judith Garber discuss the new Lown report on medication overload and highlight the family/caregiver role in preventing harm from too many medications. More
New prescription drug delivery start-ups are bypassing the FDA's regulations on off-label marketing. More
March 30-31 was a milestone in the Lown Medication Overload project, when 30 working group members came to Boston to discuss strategies for reducing medication overload. Here's what we talked about! More
Gabapentinoids like Neurontin and Lyrica are often prescribed for off-label uses. But does the evidence support this treatment? More
High drug prices have been a hot topic in politics recently, but there's another reason that our country spends so much on drug costs, write Shannon Brownlee and Judith Garber in Stat News. More
In two pieces published recently in JAMA, researchers identify important issues in cardiology guidelines, including the lack of clarity in summary statements and a worsening evidence base. More
What does it mean to be a "medical conservative"? These doctors explain why it's important to be skeptical about new medical advances until unbiased and high-quality evidence shows a clear benefit. More
In the newest edition of the American Family Physician, members of the Right Care Alliance Children's Health Council present their final list of top "Do's and Don'ts" for preventing both overuse and underuse in pediatrics. More
For conditions like mild hypertension, that depend a lot of patient behavior outside the clinic, adherence rates are typically very low. The newest piece in the Right Care Series gives physicians tips on how they can improve patient engagement. More
In a new commentary, Dr. Vinay Prasad and colleagues use a thought experiment to explain why cancer screening programs have to consider the harms as well as the benefits. More
When the majority of health professionals are experiencing feelings of exhaustion, detachment, and depression, could this possibly be problem that individuals can solve? Absolutely not. More
A new study finds that trauma care is less accessible to residents of black-majority census tracts in certain cities, demonstrating another consequence of structural violence. More
When a patient in the hospital has elevated blood pressure, but no other symptoms related to a hypertensive emergency, what should be the course of action? More
Two years after the Open Payments tool was launched, the vast majority of patients still don't know whether their doctor receives money from industry. Why? More
A new primary care model to encourage telehealth visits could be a step in the right direction, but also raises questions about provider burden. More
In health care as well as politics, expectations of unethical behavior are often driven by unspoken rules, rather than explicit instructions. More
Should we be worried about projected increases in health care spending? Or is it just the price we pay for better health? More
The pediatric field has been slower to recognize the problem of overuse, in part because there is less evidence available on overused services. A new review seeks to highlight studies that are filling these gaps in the research. More
In the COMPare trial, researchers set out to find out how prevalent outcome reporting errors are in major journals, and how these journals respond to criticism. The results were not pretty... More
As the powerful depression drug esketamine nearly FDA approval, some researchers are concerned that the approval would be lowering the bar for clinical evidence. More